Efficacy of the Novel Ciprofloxacin conjugate RLA-4784 in the murine lung model with P. aeruginosa

Project Details

StatusFinished
Effective start/end date2/10/20 → 1/10/21

Funding

  • UNIVERSITY OF CALIFORNIA SAN FRANCISCO: $22,496.20

Keywords

  • Biotechnology & Drug Development, Infectious Diseases